Sun Pharmaceuticals

Shanghvi steps down as Sun Pharma chairman; Israel Makov to take over

30 May 2012

Dilip Shanghvi, who will continue to be the managing director, is stepping down as chairman in favour of former chief executive of Israel's Teva Pharma, Israel Markov

Dr. Reddy’s, Sun Pharma, 9 others get FDA nod for generic version of Plavix

19 May 2012

Sun Pharma to buy remaining stake in Israeli unit Taro for Rs1,810 crore

19 Oct 2011

Sun Pharma resolves FDA issue at US plant

19 Sep 2011

Sun to co market Merck's Diabetes drugs in India

25 Apr 2011

Merck, Sun Pharma in generics JV

11 Apr 2011

The joint venture will develop and commercialise novel formulations and combinations of medicines in emerging markets

US FDA grants tentative approval for Sun's generic Aricept

30 Nov 2010

Sun Pharma receives tentative USFDA approval for generic Crestor

30 Sep 2010

Sun Pharma board approves stock split into Re1 shares

24 Sep 2010

Sun acquires controlling stake in Taro, Shanghvi is chairman

22 Sep 2010

After two and a half years of legal battle, Sun's subsidiaries have increased their voting rights in Taro to 65.8 per cent

Israel Supreme Court lifts injunction on Sun's acquisition of Taro

08 Sep 2010

Sun Pharma subsidiary, which holds a 36 per cent stake in Taro, said it plans to move forward to close the offer and enforce its rights under the option agreement to purchase the Levitts' controlling shares

USFDA approves Sun's generic version of Lilly's Strattera

01 Sep 2010

US court favours Sun Pharma over Eli Lilly’s cancer drug patent on

29 Jul 2010

Taro mulls next move after dismissal of US suit against Sun Pharma

17 Jul 2010

Sun Pharma announces US FDA approval for generic Flomax

16 Jul 2010

Taro case: US court rules in favour of Sun Pharma

15 Jul 2010

Sun Pharma gains 180-day marketing exclusivity for generic Exelon in the US

02 Jul 2010

Sun Pharma, Orion settle litigation over generic Stalevo and Comtan

22 Jun 2010

Sun Pharma's epilepsy drug granted US FDA approval

17 Jun 2010

Sun rejects Guggenheim's $215 million offer for Taro stake

03 Jun 2010

Sun Pharma net profit falls nearly 29 per cent to Rs898 crore

24 May 2010

US court bans Sun Pharma's generic equivalent of Sanofi's eloxatin

24 Apr 2010

Sun Pharmaceutical gets tentative US FDA approval for Alzheimer’s treatment

10 Apr 2010

Sun Pharma gets USFDA approval for generic Prometh syrup

18 Mar 2010

Sun fails to dislodge Taro directors at general body

01 Jan 2010

India's Sun Pharmaceutical Industries claimed partial success in its fight against the management of Israeli generic-drugs maker Taro Pharmaceutical Industries when most minority shareholders of Taro voted against re-election of its board members.

View details about the software product Informachine News Trackers